Andrew Burke

1.3k total citations · 1 hit paper
34 papers, 756 citations indexed

About

Andrew Burke is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andrew Burke has authored 34 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 16 papers in Infectious Diseases and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andrew Burke's work include Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (11 papers) and Infective Endocarditis Diagnosis and Management (4 papers). Andrew Burke is often cited by papers focused on Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (11 papers) and Infective Endocarditis Diagnosis and Management (4 papers). Andrew Burke collaborates with scholars based in Australia, United Kingdom and Canada. Andrew Burke's co-authors include Amber O. Molnar, Daniel F. McAuley, Gordon Guyatt, Stephen D. Walter, Neil D. Dattani, Janice Pogue, Christine Ribic, Michael Walsh, Sadeesh Srinathan and Marko Mrkobrada and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Andrew Burke

32 papers receiving 742 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index

2014 443 citations Andrew Burke et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Burke Australia	9	204	175	145	134	111	34	756
Thuva Vanniyasingam Canada	14	159 0.8×	144 0.8×	231 1.6×	70 0.5×	50 0.5×	40	675
Diane B Toll Netherlands	8	139 0.7×	75 0.4×	128 0.9×	71 0.5×	83 0.7×	11	668
Harris Rj United Kingdom	4	102 0.5×	84 0.5×	156 1.1×	81 0.6×	58 0.5×	7	609
Inajara Rotta Brazil	16	56 0.3×	88 0.5×	160 1.1×	64 0.5×	123 1.1×	41	950
Mitchell Levy United States	9	147 0.7×	110 0.6×	321 2.2×	33 0.2×	50 0.5×	15	795
Breanne Johnsen United States	12	168 0.8×	31 0.2×	84 0.6×	52 0.4×	66 0.6×	21	865
Andrew Foy United States	17	177 0.9×	120 0.7×	99 0.7×	14 0.1×	64 0.6×	94	1.1k
Juan Carlos Villar Colombia	18	552 2.7×	234 1.3×	399 2.8×	37 0.3×	36 0.3×	46	1.4k
Mahesh Ramanan Australia	17	160 0.8×	193 1.1×	192 1.3×	14 0.1×	32 0.3×	87	1.1k
Matthew B. Stanbrook Canada	20	36 0.2×	748 4.3×	128 0.9×	30 0.2×	96 0.9×	69	1.2k

Countries citing papers authored by Andrew Burke

Since Specialization

Citations

This map shows the geographic impact of Andrew Burke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Burke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Burke more than expected).

Fields of papers citing papers by Andrew Burke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Burke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Burke. The network helps show where Andrew Burke may publish in the future.

Co-authorship network of co-authors of Andrew Burke

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Burke. A scholar is included among the top collaborators of Andrew Burke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Burke. Andrew Burke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bell, Peter T., Timothy Baird, John Goddard, et al.. (2025). Evaluating the feasibility, sensitivity, and specificity of next-generation molecular methods for pleural infection diagnosis. Microbiology Spectrum. 13(2). e0196024–e0196024. 1 indexed citations

Henderson, Daniel, David W. Reid, Elizabeth M. Johnson, et al.. (2025). The complexities of elexacaftor/tezacaftor/ivacaftor therapeutic drug monitoring in a person with cystic fibrosis and Mycobacterium abscessus pulmonary disease. European Clinical Respiratory Journal. 12(1). 2458341–2458341. 2 indexed citations

Burke, Andrew, et al.. (2024). New Oxazolidinones for Tuberculosis: Are Novel Treatments on the Horizon?. Pharmaceutics. 16(6). 818–818. 7 indexed citations

Singh, Sanjay, Tawanda Gumbo, Jann‐Yuan Wang, et al.. (2024). Imipenem Pharmacokinetics/Pharmacodynamics in Preclinical Hollow Fiber Model, Dose Finding in Virtual Patients, and Clinical Evidence of Efficacy for Mycobacterium abscessus Lung Disease. The Journal of Infectious Diseases. 231(6). 1521–1531. 3 indexed citations

Burke, Andrew, et al.. (2024). A case of severe Mycobacterium thermoresistibile pneumonia. SHILAP Revista de lepidopterología. 12(3). e01308–e01308. 2 indexed citations

Dahl, Victor Næstholt, Andrew Burke, Andreas Fløe, et al.. (2024). Advantages and limitations of virtual multi-disciplinary team meetings on difficult-to-treat mycobacteria. The International Journal of Tuberculosis and Lung Disease. 28(4). 212–213.

Lu, L., Andrew Burke, Gianluigi Li Bassi, et al.. (2023). Prevalence, Risk Factors, Clinical Features, and Outcome of Influenza-Associated Pulmonary Aspergillosis in Critically Ill Patients. CHEST Journal. 165(3). 540–558. 15 indexed citations

Thomson, Rachel, Michael R. Loebinger, Andrew Burke, et al.. (2023). OPTIMA: An Open-Label, Noncomparative Pilot Trial of Inhaled Molgramostim in Pulmonary Nontuberculous Mycobacterial Infection. Annals of the American Thoracic Society. 21(4). 568–576. 10 indexed citations

Burke, Andrew, Brett McWhinney, Adrian R Tramontana, et al.. (2023). Pre-extensively Drug-Resistant Congenital Tuberculosis in an Extremely Premature Baby. Clinical Infectious Diseases. 78(1). 149–153. 1 indexed citations

10.

Burke, Andrew, et al.. (2023). In vitro susceptibility testing of imipenem-relebactam and tedizolid against 102 Mycobacterium abscessus isolates. International Journal of Antimicrobial Agents. 62(4). 106938–106938. 4 indexed citations

11.

Bell, Peter T., et al.. (2023). A mariner's tale: Invasive endotracheal Mycobacterium marinum infection. SHILAP Revista de lepidopterología. 11(10). e01211–e01211. 1 indexed citations

12.

Burke, Andrew, et al.. (2023). Medications and Monitoring in Treatment of Nontuberculous Mycobacterial Pulmonary Disease. Clinics in Chest Medicine. 44(4). 815–828. 8 indexed citations

13.

Reddy, Taryn, et al.. (2022). The IRIS paradox: Imaging findings in a case of PJP‐IRIS. SHILAP Revista de lepidopterología. 10(9). e01014–e01014. 4 indexed citations

14.

Burke, Andrew, Daniel J. Smith, Chris Coulter, et al.. (2021). Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis. Clinical Pharmacokinetics. 60(9). 1081–1102. 5 indexed citations

15.

Fitzgerald, John, et al.. (2020). Late Potentials and Early Repolarisation Are Associated With Serious Mental Illness and May Portend Increased Arrhythmic Risk. Heart Lung and Circulation. 29(10). 1476–1483. 5 indexed citations

16.

Clark, William F., Jessica M. Sontrop, Shih‐Han S. Huang, et al.. (2018). Effect of Coaching to Increase Water Intake on Kidney Function Decline in Adults With Chronic Kidney Disease. JAMA. 319(18). 1870–1870. 61 indexed citations

17.

Burke, Andrew, et al.. (2017). High Rates of Respiratory Symptoms and Airways Disease in Mental Health Inpatients in a Tertiary Centre. Respirology. 22. 32–32. 2 indexed citations

18.

Burke, Andrew, Stephen Graves, & Nicholas M. Anstey. (2015). Fever and rash from Timor: where have you been and when?. The Medical Journal of Australia. 203(8). 338–338. 4 indexed citations

19.

Brown, Annemarie, Jonathan R. Walker, Mark C. Murphy, et al.. (2015). 0166 ‘Ebola sim’ – an in-situ simulation to test standard operating procedures (SOPS) for a high risk patient pathway. A61.1–A61. 1 indexed citations

20.

Piccolo, Francesco Lo, Rahul Bhatnagar, Natalia Popowicz, et al.. (2014). Intrapleural Tissue Plasminogen Activator and Deoxyribonuclease for Pleural Infection. An Effective and Safe Alternative to Surgery. Annals of the American Thoracic Society. 11(9). 1419–1425. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact